Brief: Candel Therapeutics Q1 Net Income USD -8.861 Million
14/05/2026 13:05
May 14 (Reuters) - Candel Therapeutics Q1 operating expenses USD 16.284 million. Q1 income from operations USD -16.284 million vs. IBES estimate USD -16.8 million Q1 basic EPS USD -0.14
Recent news on Candel Therapeutics
See all newsBrief: Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Candel Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Candel Therapeutics Reports Second Quarter 2026 Financial Results And Recent Corporate Highlights
Candel Therapeutics Inc expected to post a loss of 24 cents a share - Earnings Preview
Brief: Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)